Nanomedicines for Breast Cancer Theranostics

<p>1. Nanomedicine: next generation modality of breast cancer therapeutics<br>2. Physical and Chemical properties of nanostructures<br>3. Biological Perspectives of Hybrid nanostructures<br>4. Novel hybrid nanostructures in breast cancer nanomedicine<br>5. Synergy between nanoparticles and breast cancer theranostics<br>6. Remotely stimulated Nano medicine for breast cancer therapy<br>7. Functional Nanostructures for drug resistant breast cancer theranostics<br>8. Nanomedicine for early diagnosis of breast cancer<br>9. Nanomedicine strategies for chemoresistant breast cancer theranostics<br>10. Cellular Interaction and Toxicity of Nanostructures<br>11. Nano-pharmacokinetics, pharmacodynamics (PK/PD) and clinical relationship<br>12. A New Approach for Cancer Treatment: from Specific Induction of Breast Cancer to Innovative Gold-Nanoparticle Mediated Thermal Therapies<br>13. Development in efficacy assessment in relevant oncology models for breast cancer nanomedicine<br>14. Consensus protocols for animal experimentation and nanomedicine trials at clinical stage in breast cancer<br>15. Current development in toxicity, clinical trials guidelines for regulatory aspects of breast cancer nanomedicines<br>16. Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine</p>